Selective up-regulation of P2X4-receptor gene expression by interferon-γ in vascular endothelial cells

Journal of Pharmacological Sciences

Volumn 107, Issue 4, 2008, Pages 419-427

  Tang, Yan ^a,b   Matsuoka, Isao ^a,c   Ono, Tomoyuki ^a   Inoue, Kazuhide ^d   Kimura, Junko ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b WUHAN UNIVERSITY   (China)

^c TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

ATP; Endothelial cell; Interferon ; P2X4 receptor; Signal transducer and activator of transcription 1 (STAT1)

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CALCIUM ION; CYCLOHEXIMIDE; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON; JANUS KINASE INHIBITOR; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PHOSPHOLIPASE C INHIBITOR; PURINERGIC P2X4 RECEPTOR; STAT1 PROTEIN; URIDINE TRIPHOSPHATE; WORTMANNIN;

ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; PATCH CLAMP; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 50149111313     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08073FP     Document Type: Article

References (39)

1. Ralevic V, Burnstock G. Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect. 2003;16:133-140.
2. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. 2006;58:58-86.
3. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol. 2002;22:364-373.
4. 1 receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. Mol Pharmacol. 2002;62:1438-1445.
5. de Nucci G, Gryglewski RJ, Warner TD, Vane JR. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci U S A. 1988;85:2334-2338.
6. 2+ influx into human endothelial cells via P2X4 purinoceptors. Circ Res. 2000;87:385-391.
7. Wang L, Karlsson L, Moses S, Hultgardh NA, Andersson M, Borna C, et al. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol. 2002;40:841-853.
8. 2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem. 2004;279:35679-35686.
9. Pirotton S, Communi D, Motte S, Janssens R, Boeynaems JM. Endothelial P2-purinoceptors: subtypes and signal transduction. J Auton Pharmacol. 1996;16:353-356.
10. 2 receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed. Br J Pharmacol. 2002;136:847-856.
11. Guns PJ, Korda A, Crauwels HM, Van Assche T, Robaye B, Boeynaems JM, et al. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta. Br J Pharmacol. 2005;146:288-295.
12. 2-deficient mice. Br J Pharmacol. 2006;147:569-574.
13. Kaiser RA, Buxton IL. Nucleotide-mediated relaxation in guinea-pig aorta: selective inhibition by MRS2179. Br J Pharmacol. 2002;135:537-545.
14. 2+ influx into pulmonary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2003;285:H793-H803.
15. 4-deficient mice. Nat Med. 2006;12:133-137.
16. Abbracchio MP, Burnstock G. Purinergic signalling: pathophysiological roles. Jpn J Pharmacol. 1998;78:113-145.
17. 2 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 2003;424:778-783.
18. Verderio C, Matteoli M. ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-γ. J Immunol. 2001;166:6383-6391.
19. 7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J Leukoc Biol. 1998;64:265-273.
20. 7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-γ in the human THP-1 monocytic cell line. J Immunol. 1996;157:5627-5637.
21. Buell G, Lewis C, Collo G, North RA, Surprenant A. An antagonist-insensitive P2X receptor expressed in epithelia and brain. Embo J. 1996;15:55-62.
22. 7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation. Jpn J Pharmacol. 2002;88:428-435.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
24. Ohkubo S, Kimura J, Matsuoka I. Correlation between adenine nucleotide-induced cyclic AMP elevation and extracellular adenosine formation in NG108-15 cells. Jpn J Pharmacol. 2000;84:325-333.
25. 2B receptor. J Neurochem. 2001;76:872-880.
26. Ramirez AN, Kunze DL. P2X purinergic receptor channel expression and function in bovine aortic endothelium. Am J Physiol Heart Circ Physiol. 2002;282:H2106-H2116.
27. i increase in NG108-15 cells. Jpn J Pharmacol. 2002;89:302-308.
28. Kaiho H, Kimura J, Matsuoka I, Kumasaka T, Nakanishi H. ATP-activated nonselective cation current in NG108-15 cells. J Neurochem. 1996;67:398-406.
29. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163-189.
30. Marrero MB, Venema VJ, Ju H, He H, Liang H, Caldwell RB, et al. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J. 1999;2:335-340.
31. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature. 1996;379:645-648.
32. Watson JL, Ansari S, Cameron H, Wang A, Akhtar M, McKay DM. Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-γ but not by IL-4. Am J Physiol Gastrointest Liver Physiol. 2004;287:G954-G961.
33. +-ATPase activity and molecular events downstream of interferon-γ receptor stimulation. Br J Pharmacol. 2004;142:1281-1292.
34. Deb DK, Sassano A, Lekmine F, Majchrzak B, Verma A, Kambhampati S, et al. Activation of protein kinase C delta by IFN-γ. J Immunol. 2003;171:267-273.
35. 7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol. 2003;171:5442-5446.
36. Di VF, Solini A. P2 receptors: new potential players in atherosclerosis. Br J Pharmacol. 2002;135:831-842.
37. Matsuoka I, Ohkubo S. ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases. J Pharmacol Sci. 2004;94:95-99.
38. 2B receptors expressed in Xenopus laevis oocytes: involvement of a rapid and localized adenosine formation by ectonucleotidases. Mol Pharmacol. 2002;61:606-613.
39. Niemela J, Henttinen T, Yegutkin GG, Airas L, Kujari AM, Rajala P, et al. IFN-α induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5′-nucleotidase) up-regulation. J Immunol. 2004;172:1646-1653.